Gullimex attracts investor Holland Capital for further growth
Borne / Amsterdam, 10th of March 2025 – Investment firm Holland Capital is investing in Gullimex, a strong player in measurement, quality, and control solutions within the food and medical sectors. Holland Capital’s investment provides Gullimex the opportunity to realize its growth ambitions.
Growing quality standards
The importance of food safety, patient safety, and hygiene continues to grow in a market characterized by increasingly stringent regulations and rising expectations regarding quality and efficiency. Gullimex supports businesses and institutions in navigating this dynamic and demanding environment, optimizing their processes through its role as an advisor, premium brand supplier, and service partner.
Gullimex ensures consistent quality measurements, optimal hygiene, and safe production within mission-critical processes. The company achieves this through an integrated combination of hardware, software, and services, providing customers with solutions that directly address the specific needs and challenges of the food and medical sectors.
Investment for growth
Gullimex aims to become the leading European provider of measurement, quality, and control solutions, leveraging data to create value for the food and medical industries. With Holland Capital’s investment, the company can achieve its growth ambitions both organically and through strategic acquisitions.
Maarten Snijders, Investment Director AgriFood-Tech at Holland Capital, said: “We are proud to support Gullimex in achieving its ambitions. As an investor with years of experience in Tech, AgriFood, and Healthcare, we aim to contribute to Gullimex’s international growth and its mission to create even more value for all its partners.”
Lucien Kwakkel, CEO of Gullimex, added: “We value Holland Capital as a strategic partner that not only invests in our growth but also actively supports us with expertise, experience, a strong network, and a hands-on mentality. Thanks to their experience and vision, we can further strengthen our position in key markets and accelerate our ambitions both nationally and internationally.”
About Gullimex
Founded in 1981, Gullimex supports a large customer base within the food and medical sectors with measurement and data recording solutions. The team of 60+ experts is active in the fields of food safety, patient safety, and hygiene. Gullimex has offices in the Netherlands, Belgium, and Germany.
About Holland Capital
For over 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the common goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With its specialized sector teams, the firm focuses on Healthcare, Technology, and AgriFood-Tech. It understands the dynamics and opportunities within these sectors and has an extensive network.
Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery
Sirius Medical announces CE mark for Pintuition: a non-radioactive localization system to improve breast cancer surgery Eindhoven, June 16, 2020 – Sirius Medical, a MedTech startup, announced that it has received CE mark approval for Sirius Pintuition. With its debut...
Sirius Medical ontvangt CE-markering voor Pintuition: een niet radioactief lokalisatiesysteem ter verbetering van borstkankeroperaties
Sirius Medical ontvangt CE-markering voor Pintuition: een niet-radioactief lokalisatiesysteem ter verbetering van borstkankeroperaties Eindhoven, 16 Juni 2020 Sirius Medical, een medtech startup, kondigt aan dat het CE-markering heeft ontvangen voor Sirius...
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers
CytoSMART to donate 100 live-cell imaging systems to assist COVID-19 researchers Eindhoven, The Netherlands - 22 April 2020, - CytoSMART Technologies is to donate 100 mini live-cell imaging systems to researchers in high containment labs worldwide. Labs working to...
Yenlo benoemd tot Platinum VAR, de hoogste WSO2 Reseller status
Yenlo benoemd tot Platinum VAR, de hoogste WSO2 Reseller statusYenlo is benoemd tot WSO2 Platinum Value-Added Reseller als erkenning voor de behaalde successen en het leveren van de beste opensource integratie- en API-managementoplossingen gebaseerd op het WSO2...
Yenlo Achieves Highest WSO2 Reseller Status as a Platinum VAR
Yenlo Achieves Highest WSO2 Reseller Status as a Platinum VAR Yenlo was named a WSO2 Platinum Value-Added Reseller in recognition of its success in growing global customer adoption and delivering best-in-class open source integration and API management solutions based...
Portfolio company Inno4Life sold to the Swiss company Dec Group
Portfolio company Inno4Life sold to the Swiss company Dec Group Amsterdam, April 16, 2020 - Earlier this month, Inno4Life, a manufacturer of machines for the pharmaceutical industry, was sold to the Swiss Dec Group. Inno4Life's management will remain actively involved...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl